819 related articles for article (PubMed ID: 12368305)
21. The U3 promoter region of the acutely lethal simian immunodeficiency virus clone smmPBj1.9 confers related biological activity on the apathogenic clone agm3mc.
Dittmar MT; Cichutek K; Fultz PN; Kurth R
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1362-6. PubMed ID: 7877983
[TBL] [Abstract][Full Text] [Related]
22. Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.
Ren W; Mumbauer A; Zhuang K; Harbison C; Knight H; Westmoreland S; Gettie A; Blanchard J; Cheng-Mayer C
Retrovirology; 2013 Jan; 10():9. PubMed ID: 23369442
[TBL] [Abstract][Full Text] [Related]
23. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
Igarashi T; Donau OK; Imamichi H; Dumaurier MJ; Sadjadpour R; Plishka RJ; Buckler-White A; Buckler C; Suffredini AF; Lane HC; Moore JP; Martin MA
J Virol; 2003 Dec; 77(24):13042-52. PubMed ID: 14645561
[TBL] [Abstract][Full Text] [Related]
24. Replication-competent variants of human immunodeficiency virus type 2 lacking the V3 loop exhibit resistance to chemokine receptor antagonists.
Lin G; Bertolotti-Ciarlet A; Haggarty B; Romano J; Nolan KM; Leslie GJ; Jordan AP; Huang CC; Kwong PD; Doms RW; Hoxie JA
J Virol; 2007 Sep; 81(18):9956-66. PubMed ID: 17609282
[TBL] [Abstract][Full Text] [Related]
25. SIVagm: genetic and biological features associated with replication.
Müller MC; Barré-Sinoussi F
Front Biosci; 2003 Sep; 8():d1170-85. PubMed ID: 12957815
[TBL] [Abstract][Full Text] [Related]
26. Enhanced infectivity of an R5-tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina).
Chen Z; Huang Y; Zhao X; Skulsky E; Lin D; Ip J; Gettie A; Ho DD
J Virol; 2000 Jul; 74(14):6501-10. PubMed ID: 10864663
[TBL] [Abstract][Full Text] [Related]
27. A replication-competent, neutralization-sensitive variant of simian immunodeficiency virus lacking 100 amino acids of envelope.
Johnson WE; Morgan J; Reitter J; Puffer BA; Czajak S; Doms RW; Desrosiers RC
J Virol; 2002 Mar; 76(5):2075-86. PubMed ID: 11836385
[TBL] [Abstract][Full Text] [Related]
28. Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains.
Lusso P; Earl PL; Sironi F; Santoro F; Ripamonti C; Scarlatti G; Longhi R; Berger EA; Burastero SE
J Virol; 2005 Jun; 79(11):6957-68. PubMed ID: 15890935
[TBL] [Abstract][Full Text] [Related]
29. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of simian immunodeficiency virus SIVMne infection affect neutralizing antibody recognition, syncytium formation, and macrophage tropism but not replication, cytopathicity, or CCR-5 coreceptor recognition.
Rudensey LM; Kimata JT; Long EM; Chackerian B; Overbaugh J
J Virol; 1998 Jan; 72(1):209-17. PubMed ID: 9420217
[TBL] [Abstract][Full Text] [Related]
30. Role of V3 independent domains on a dualtropic human immunodeficiency virus type 1 (HIV-1) envelope gp120 in CCR5 coreceptor utilization and viral infectivity.
Foda M; Harada S; Maeda Y
Microbiol Immunol; 2001; 45(7):521-30. PubMed ID: 11529558
[TBL] [Abstract][Full Text] [Related]
31. Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors.
Riddick NE; Wu F; Matsuda K; Whitted S; Ourmanov I; Goldstein S; Goeken RM; Plishka RJ; Buckler-White A; Brenchley JM; Hirsch VM
J Virol; 2015 Dec; 90(5):2316-31. PubMed ID: 26656714
[TBL] [Abstract][Full Text] [Related]
32. Derivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus.
Swanstrom AE; Haggarty B; Jordan APO; Romano J; Leslie GJ; Aye PP; Marx PA; Lackner AA; Del Prete GQ; Robinson JE; Betts MR; Montefiori DC; LaBranche CC; Hoxie JA
J Virol; 2016 May; 90(10):4966-4980. PubMed ID: 26937037
[TBL] [Abstract][Full Text] [Related]
33. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
Maeda Y; Foda M; Matsushita S; Harada S
J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
[TBL] [Abstract][Full Text] [Related]
34. Unique pattern of convergent envelope evolution in simian immunodeficiency virus-infected rapid progressor macaques: association with CD4-independent usage of CCR5.
Dehghani H; Puffer BA; Doms RW; Hirsch VM
J Virol; 2003 Jun; 77(11):6405-18. PubMed ID: 12743298
[TBL] [Abstract][Full Text] [Related]
35. A simian immunodeficiency virus V3 loop mutant that does not efficiently use CCR5 or common alternative coreceptors is moderately attenuated in vivo.
Pöhlmann S; Münch J; Aziz S; Reeves JD; Otto C; Leslie GJ; Hofmann H; Puffer BA; Baribaud F; Marzi A; Gramberg T; Chen Z; Stolte N; Haaft PT; Heeney JL; Stahl-Hennig C; Mätz-Rensing K; Schneider T; Doms RW; Kirchhoff F
Virology; 2007 Apr; 360(2):275-85. PubMed ID: 17126374
[TBL] [Abstract][Full Text] [Related]
36. V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies.
Laakso MM; Lee FH; Haggarty B; Agrawal C; Nolan KM; Biscone M; Romano J; Jordan AP; Leslie GJ; Meissner EG; Su L; Hoxie JA; Doms RW
PLoS Pathog; 2007 Aug; 3(8):e117. PubMed ID: 17722977
[TBL] [Abstract][Full Text] [Related]
37. CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses.
Borsetti A; Parolin C; Ridolfi B; Sernicola L; Geraci A; Ensoli B; Titti F
J Virol; 2000 Jul; 74(14):6689-94. PubMed ID: 10864687
[TBL] [Abstract][Full Text] [Related]
38. Rapid CD4+ T-lymphocyte depletion in rhesus monkeys infected with a simian-human immunodeficiency virus expressing the envelope glycoproteins of a primary dual-tropic Ethiopian Clade C HIV type 1 isolate.
Cayabyab M; Rohne D; Pollakis G; Mische C; Messele T; Abebe A; Etemad-Moghadam B; Yang P; Henson S; Axthelm M; Goudsmit J; Letvin NL; Sodroski J
AIDS Res Hum Retroviruses; 2004 Jan; 20(1):27-40. PubMed ID: 15000696
[TBL] [Abstract][Full Text] [Related]
39. Human immunodeficiency virus type 1 IIIB selected for replication in vivo exhibits increased envelope glycoproteins in virions without alteration in coreceptor usage: separation of in vivo replication from macrophage tropism.
Miller ED; Duus KM; Townsend M; Yi Y; Collman R; Reitz M; Su L
J Virol; 2001 Sep; 75(18):8498-506. PubMed ID: 11507195
[TBL] [Abstract][Full Text] [Related]
40. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
Chen Z; Gettie A; Ho DD; Marx PA
Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
